Kennedy has been criticized for making false medical claims. He has also vowed to purge the U.S. Food and Drug Administration ...

Over the past year, the question has been coming in from everywhere – from my patients and family members, from colleagues ...

JP Morgan Chase analysts say they’re ‘not surprised’ sector has come ‘under pressure’ since Kennedy’s nomination ...

It’s been a year since the gene-editing treatment Casgevy was approved for sickle cell disease and a related blood disorder.

Shares of major U.S. drugmakers fell on Friday after President-elect Donald Trump picked anti-vaccine activist Robert F.

Shares of major U.S. drugmakers fell on Friday after U.S. President-elect Donald Trump picked Robert F. Kennedy Jr., who has ...

Halozyme makes 2 billion euro buyout offer for drug developer Evotec November 14, 2024 Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends ...

Last October Novo Nordisk announced that it had shelved plans ... as injectable insulin – and says a future advance in drug delivery could still make it a reality. An oral version of insulin ...

A new clinical trial is hoping to show that treatment with a psychedelic drug in development at UK ... the therapeutic effect of psychedelics for substance use disorders. “We are proud to ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...